A2A Pharmaceuticals, Inc. - Insider Trading & Ownership

Entity
Company
Location
59 5 Th Ave, New York, NY
Summary
The estimated value of insider holdings of A2A Pharmaceuticals, Inc. is at least $13.2M dollars as of June 2, 2023. A2A Pharmaceuticals, Inc. is the 10%+ Owner of Biomea Fusion, Inc. and owns shares of Biomea Fusion, Inc. (BMEA) stock worth about $13.2M.
All Insider Reports
All Insider Reports

Ownership of A2A Pharmaceuticals, Inc.

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BMEA Biomea Fusion, Inc. 10%+ Owner $13.2M May 31, 2023

Insider Transactions Reported by A2A Pharmaceuticals, Inc.:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.